Diabetes News

 

Fourth Major Insulin Manufacturer Enters US Market with Semglee Launch


Semglee (insulin glargine), from Mylan and Biocon, is now available by prescription in the United States in vial and pre-filled pen presentations.MORE

With SAG-AFTRA Healthcare Changes, Can T1Ds Stay in the Arts?


With recently announced SAG-AFTRA healthcare changes, do the majority of people with T1D realistically have the option to choose a profession in the arts? MORE

JDRF Announces Updated Strategy, Renewed Focus in Light of COVID-19


Amidst COVID-19, JDRF prioritizing work in their portfolio that they see as having the highest likelihood for cures and life changing advances for diabetes.MORE

Study Links COVID-19 to Increased Rates of DKA at Diagnosis in Children


In a German study from March to May 2020, nearly half of minors had DKA at Type 1 diabetes diagnosis - double previous years - amidst COVID-19.MORE

United Healthcare to Begin Covering Tandem Insulin Pumps


On July 1, 2020, United Healthcare (UHC) announced they will begin covering the Tandem t:slim X2 insulin pump, a departure from UHC’s four-year policy to only provide health insurance coverage for M...MORE

Preventing and Delaying Type 1 Diabetes: Updates From the Teplizumab Trial


Half of those treated with teplizumab remain diabetes-free, compared to 22% of those taking placebo, and the delay in diabetes onset was close to 3 years.MORE

Disparities in Diabetes and Diabetes Care—What Can We Do About It?


At this ADA 2020 session, systemic racism and implicit bias were clear contributors to poor health and healthcare outcomes for Black and Latinx communities.MORE

T1D Exchange + Beyond Type 1 Marathon Study Presented at ADA 2020


The Beyond Type Run team has taken on 26.2 miles to not only raise awareness and funds for T1D, but to provide crucial data for a study pertaining to management of Type 1 before, during, and after a m...MORE

One Drop Announces New Overnight Hypo Predictions and Long-Term Health Forecasts at ADA 2020


One Drop unveiled new AI-powered predictions for blood glucose, A1C, blood pressure, and weight up to six months in advanceMORE

FreeStyle Libre 2 Approved for Use in U.S.


Those living with Type 1 diabetes in the U.S. now have the opportunity to manage their disease utilizing the perks of Abbott’s Freestyle Libre 2. MORE

Closed Loop Updates: Omnipod Horizon and Medtronic 780G data presented at ADA 2020


Data from four new clinical trials involving Hybrid Closed Loop systems, Medtronic 780G and Omnipod 5 Powered by Horizon was presented at ADA 2020.MORE

New Research Resource from Beyond Type 1 Aims to Bridge the Gap Between Science and Community


A new collection of resources shared today by Beyond Type 1 breaks down the most impactful current Type 1 diabetes research into quick and easy to understand information. MORE

Medicare Part D Senior Savings Model Caps Insulin Costs at $35 per Month


The Senior Savings Model caps out of pocket insulin costs at $35 per month for seniors enrolled in eligible plans.MORE

England’s NHS Releases Study on Risk of COVID-19 for People with Diabetes


This week, the National Health Service (NHS) in England released the first study of its kind, breaking down COVID-19 mortality risk by type of diabetes.MORE

Armed For Diabetes Created to Help Veterans With Resources For Better Diabetes Management


Armed for Diabetes highlights continuous glucose monitoring prescribing guidelines for veterans.MORE

Roche Offers Free Access to mySugr Pro During COVID-19


With the rise of telemedicine during COVID-19, free access to mySugr Pro will help people stay connected to their healthcare team. MORE

Minnesota Passes the Alec Smith Insulin Affordability Act


The Alec Smith Insulin Affordability Act was signed into law in Minnesota, providing MN residents options for emergency and ongoing insulin access for those who qualify.MORE

Novo Offers Free 90-Day Insulin Supply to People Recently Uninsured Due to COVID-19


Novo Nordisk announces program offering a free 90-day supply of Novo Nordisk insulin for those who have recently lost their health insurance coverage due to a change in job status because of COVID-19....MORE

Beyond Type 1 Asks Congress To Support Expanded Paid Leave For Chronic Conditions During COVID-19


Beyond Type 1 joined 156 other organizations in urging Congress to expand paid leave for those with chronic illness, who are at higher risk for complications from COVID-19.MORE

FreeStyle Libre Approved by FDA for Hospitalized Patients During COVID-19 Pandemic


Abbott's FreeStyle Libre 14 day system will allow doctors to remotely monitor their patient's glucose levels. MORE

New Program Offers $35 Monthly Copays for Lilly Insulins


Eli Lilly announced a new program that allows people in the US to fill their monthly prescription of Lilly insulin for $35 per month with a copay card.MORE

Senseonics Suspends Commercial US Sales of Eversense in Response to COVID-19


On March 26, Senseonics suspended all commercial sales of the Eversense continuous glucose monitor (CGM) in the United States.MORE

New Insulin Approval Pathway Could Increase Competition


The new regulatory pathway “is expected to increase patient access, adding more choices and potentially reducing costs of these vital therapies.”MORE

The Power in Numbers: Change.org’s Affordable Insulin For All Movement


As insulin prices continue to increase in the United States, Change.org is equipping those affected with the tools to speak out.MORE

New Medicare Plan Will Cap Insulin Copays at $35


On March 11, the Centers for Medicare & Medicaid Services (CMS) launched a new plan for some Medicare Part D participants to pay a maximum $35 copay for their monthly supply of insulin. MORE

The FAA continues to ground commercial pilots with insulin-dependent diabetes


Pilots with diabetes remain in the dark following the Federal Aviation Administration's updated medical certification guidelines.MORE

Omnipod Closed Loop Technology to be Compatible with both Abbott and Dexcom CGMs


Abbott and Dexcom announced formal partnerships with Insulet to be compatible as CGMs on the Omnipod Horizon Automated Insulin Delivery System. MORE

Beyond Type 1 Launches in Five New Languages to Better Serve the Global Diabetes Community


Beyond Type 1 announced today the launch of websites in Dutch, French, German, Italian, and Swedish. The multi-language expansion is made possible with support from partners Dexcom and Insulet.MORE

FDA Issues Class I Recall of Certain Medtronic Insulin Pumps


The FDA announced Wednesday that it has issued a Class 1 recall of Medtronic MiniMed 600 Series insulin pumps, after reports of 2,175 injuries and 1 death.MORE

New Evidence Shows Vital Importance of Screening For T1D in Children


By screening for Type 1 diabetes in children, Bavaria was able to decrease rates of diabetic ketoacidosis at diagnosis.MORE

Omnipod Dash System Launches in First European Countries


On December 18, Insulet announced that the Omnipod DASH™ Insulin Management System is now officially available in the UK and the Netherlands. MORE

Join the Fit with Diabetes Challenge


Beyond Type 1 met up with Christel Oerum from Diabetes Strong for a chat about fitness and her next Fit With Diabetes Challenge which is kicking off on January 3.MORE

Tandem’s Control-IQ Hybrid Closed Loop Approved by the FDA


The FDA announced the approval of the Control-IQ Hybrid Closed Loop System from Tandem Diabetes Care. The system sees the t:slim X2 insulin pump and Dexcom G6 continuous glucose monitor working togeth...MORE

Gvoke HypoPen Now Available


On September 10 the FDA approved the Gvoke HypoPen and Gvoke PFS, emergency glucagon rescue devices for the treatment of severe hypoglycemia.MORE

Half-Price Generics of NovoLog and NovoLog Mix Announced by Novo Nordisk


Novo Nordisk announced that authorized generic versions of NovoLog and NovoLog Mix will be made available on January 2, 2020.MORE

JDRF Launches Center of Excellence to Accelerate Cure for Type 1 Diabetes


On September 4, JDRF announced the launch of its Northern California Center of Excellence, dedicated to focused efforts on research and breakthroughs to cure Type 1 diabetes.MORE

People With Diabetes Forgoing Basic Needs in Order to Survive According to New Studies


According to two studies presented at the American Association of Diabetes Educators 2019 Annual Conference, people with diabetes are forgoing basic needs in the face of rising healthcare costs and ta...MORE

Nasal Glucagon Baqsimi Approved by the FDA


On Thursday, the Food and Drug Administration approved Eli Lilly and Company's Baqsimi, a non-injectable, nasal glucagon and the first of its kind. MORE

Senate Bill Aims to Cut Price of Insulin by 75%


The "Insulin Price Reduction Act" would create a new pricing model for insulin, incentivizing manufacturers to lower list prices to 2006 prices.MORE

New Guidance from the US Treasury Opens Door to High Deductible Exemptions for Diabetes Care


The U.S. Treasury issued new guidance which aims to make accessing medications for chronic conditions easier under some insurance plans.MORE

New Senate Bill Would Speed up Availability of Generic Insulin in the U.S.


The Affordable Insulin Approvals Now Act is a bipartisan bill intended to speed up the approval process of generic insulins in order to help lower costs.MORE

JDRF Advocates Urge Congress to Renew Funding for T1D Research


On the final day of the 2019 JDRF Children's Congress, advocates implored the U.S. Special Committee on Aging to renew the Special Diabetes Program.MORE

New Bipartisan ‘Emergency Access’ Bill Introduced to Lower Insulin Costs


Democratic Senator Tina Smith announced Thursday the rollout of a bipartisan bill to bring down insulin prices. The legislation features the set-up of an emergency insulin assistance program, which wo...MORE

T1D Exchange and Tidepool Partner with Beyond Type 1 to Study Athletes with Type 1 Diabetes 


Beyond Type 1 announces collaborative research study produced with T1DExchange + Tidepool, focusing on glycemic variability and exercise. MORE

Nonprofits Announce Groundbreaking Research Initiative


The Parker Institute, JDRF and The Leona M. and Harry B. Helmsley Charitable Trust announced a research initiative to study immunotherapy-induced diabetes. MORE

Colorado Becomes First State to Pass Bill Capping Insulin Costs


On Wednesday, May 22, Colorado became the first state in the U.S. to put a price cap on insulin.MORE

FDA Approves New Treatment for Diabetic Retinopathy


Regeneron Pharmaceuticals announced that the FDA has approved EYLEA (aflibercept) to treat all stages of diabetic retinopathy.MORE

Express Scripts Won’t Cover Lilly’s Generic Insulin


The largest PBM in the U.S. recently released a list of formulary exclusions that included 'Insulin Lispro' as an excluded medication. MORE

Omnipod DASH System Now Available in the U.S.


The Omnipod DASH™ Insulin Management System is now officially available in the United States following a limited marketing release.MORE

European Commission Approves Zynquista, First Dual SGLT Inhibitor for T1D


Zynquista is the first dual SGLT1 and SGLT2 inhibitor approved for use in Type 1 diabetes, and the second oral medication approved for use in Type 1 diabetes. MORE

Woman’s Insulin Confiscated By Airport Security


A woman boarding a flight in the UK had her insulin taken from her by airport security and subsequently boarded her flight without it.MORE

DIY Loop Now Compatible with Omnipod


Loop announced that a testing branch of their DIY Loop is now compatible with the current 'Eros' generation of Omnipod, and available to the public.MORE

Previously Healthy from Beyond Type 1 Named Webby People’s Voice Award Winner


Hailed as the “Internet’s highest honor” and “the Oscars of the Internet” The Webby Awards are presented by the International Academy of Digital Arts and Sciences (IADAS) honoring excellence...MORE

Insulin Manufacturers and PBMs Testify Before Congress


The hearing was contentious throughout, with House members grilling both the manufacturers and the PBM representatives about the reasons for high costs.MORE

JDRF’s New CEO Aaron Kowalski Talks to Beyond Type 1


Beyond Type 1 spoke with newly-appointed JDRF CEO Aaron Kowalski about his priorities, the future of T1D research and treatment options, and how his diabetes has informed his work. MORE

Cigna Plan Could Cap Insulin Costs at $25 a Month


Cigna and Express Scripts announced on Wednesday that they would be lowering the out-of-pocket cost of insulin for some patients with diabetes.MORE

‘Previously Healthy’ Nominated for Best Writing (Editorial) in the 23rd Annual Webby Awards


Type 1 diabetes story nominated for a Webby alongside work from BBC Future, The Guardian, The New Yorker, and The Intercept.MORE

First Oral Medication to Treat T1D Approved in Europe


The European Commission (EC) has approved the use of Forxiga (dapagliflozin) as an add-on treatment to insulin therapy for use in in patients with T1D who have a BMI ≥ 27 kg/m2MORE

FDA Declines to Approve First Oral Medication for Type 1 Diabetes


The FDA issued a Complete Response Letter for the SGLT-1/2 inhibitor Zynquista (sotagliflozin), declining to approve it for use in T1D at this time. MORE

Senseonics Appoints Francine R. Kaufman, M.D. as Chief Medical Officer


Francine R. Kaufman, M.D., a member of Beyond Type 1’s Science Advisory Council, was appointed Chief Medical Officer at Senseonics.MORE

Half-Price Generic of Humalog Insulin Launched by Lilly


On Monday, March 4, Lilly Diabetes announced in a press release that an authorized generic version of Humalog insulin will be available in United States pharmacies for half the list price of Humalog.MORE

Pharma Execs Testify Before Senate on High Drug Prices


Executives from pharmaceutical companies were called on to testify before the Senate Finance Committee to explain the soaring cost of prescription drug prices in the U.S.MORE

UCSF Team First to Grow Insulin-Producing Cells from Human Stem Cells


Researchers at UCSF have created insulin-producing cells from human stem cells, an incredible breakthrough and benchmark on the road to curing Type 1 diabetes. This is the first time scientists have b...MORE

Teen with T1D Rationed Insulin to Help Parents


Dillon Hooley started rationing insulin at the beginning of 2018, in an effort to help his parents struggling with finances.MORE

Insulin Manufacturers Called on to Explain Skyrocketing Prices


On Tuesday, a group of U.S. Senators led by Patty Murray (D-WA) sent letters to executives at Eli Lilly, Novo Nordisk, and Sanofi demanding information about the rising prices of insulin.  MORE

UnitedHealthcare Decision — A Step Backwards for Pump Access


UnitedHealthcare's announcement of a preferred insulin pump for pediatric patients has been denounced by Beyond Type 1 and JDRF.MORE

National Health Services to Provide Free CGMs to Pregnant Women with T1D in UK


National Health Services England announced Monday that it would offer continuous glucose monitors to all pregnant women with T1D by 2021. MORE

FDA Advisory Vote Split 8-8 on SGLT Inhibitor for T1D


Votes on Zynquista from panel members on the Endocrinologic and Metabolic Drugs Advisory Committee were split 8 to 8. This was the first ever regulatory review for an SGLT inhibitor for use in Type 1 ...MORE

Government Shutdown Leads to Insulin Rationing


Government workers are increasingly unable to afford basic necessities like food, power, and critical medications like insulin.MORE

Congressman Introduces “Insulin Access For All Act” for Medicaid and Medicare Beneficiaries


Representative Bobby Rush (D-Ill) introduced the Insulin Access For All Act to eliminate the cost-sharing requirement for patients on Medicare and MedicaidMORE

All About the Tidepool Loop Program


In Fall of 2018, Tidepool announced plans to deliver an officially supported, FDA-regulated Loop app that will be available via the App Store. They’re calling it the “Tidepool Loop”MORE

Research Team Delays Onset of Type 1 Diabetes in Mice


Dr. Massimo Pietropaolo and his team of experimenters at Baylor College of Medicine and the University of Michigan Medical School have determined that certain B cells may have the capacity to delay th...MORE

FDA Commissioner Makes Statement on Insulin Pricing


Today, the United States FDA Commissioner Scott Gottlieb, M.D., released a statement detailing a handful of new guidances designed to increase competition and bring down prices across the insulin mark...MORE

Type 1 Diabetes in Ghana: A Global Community Discussion


James Mansfield details a chat facilitated by Type One Run and Diabetes Youth Care Ghana during which those in attendance were brought up to speed on the various unique challenges faced by Ghanaians w...MORE

Dexcom Donates $25,000 to Beyond Type 1


Social media campaign #NoMoreFingerpricks raises funds and awareness for diabetes researchMORE

Introducing Francine Kaufman: Newest Member of Science Advisory Council


Meet Francine Kaufman M.D., the newest member of the Beyond Type 1 Science Advisory Council! Dr. Kaufman recently spoke with Beyond Type 1 about her history of treating diabetes, her work abroad, the...MORE

New Study Reveals the Power of the Diabetes Online Community


You may know the power of the diabetes online community, but does your doctor? Do experts understand what it really means when community members build relationships through social media in the #DOC?MORE

ViaCyte Secures $80 Million in Funding to Further Cell-Based Treatment for Diabetes


ViaCyte is leading the charge in stem cell research and regenerative medicine. Their goal? Cell-based long term diabetes treatments - a “functional cure” for Type 1 diabetes. MORE

National Health Services To Offer Free Glucose Monitors for T1D in the UK


Beginning April 1, people with Type 1 diabetes in the UK will have the FreeStyle Libre system completely covered, ending issues with access many are currently facing.MORE

Meet Alexi on the Beyond Type 1 Leadership Council


Alexi is a writer, artist and actress in the Bay Area. She studied at the New School University in Manhattan as well as the Lee Strasberg Theatre & Film Institute. She has written for multiple pub...MORE

Giving Thanks For Dr. Lois Jovanovic (1947-2018)


Midwife Jessica Lynn reflects on her time spent under Dr. Lois Jovanovic's tutelage and shares what feels were her biggest contributions to the world of T1D.MORE

Crystal Bowersox and Brett Ryan Stewart release new single “The Stuff” to raise awareness for Type 1 diabetes


The two talented musicians operate out of Nashville and have both lived with Type 1 diabetes for most of their lives.MORE

Global Diabetes Non-Profit Beyond Type 1 Celebrates World Diabetes Day With Guiness World Record Attempt


Beyond Type 1 is celebrating Sir Frederick Banting’s 127th birthday on Wednesday, November 14th with a coalition of almost 50 organizations attempting to break the Guinness World Record for most con...MORE

Diabeloop Obtains CE Marking for DBLG1


Diabeloop, a French medical technology company that specializes in creating accessible innovations for the Type 1 diabetes community, has obtained CE marking for its DBLG1 System.MORE

The Deductible Problem


Over the past two decades, deductibles have been steadily rising and a greater percentage of Americans have been enrolling in high deductible health plans.MORE

Diabetes Patients Are Being Denied Access to Life-Changing Technology


A recent survey conducted by Dexcom and Beyond Type 1 has revealed that many people with Type 1 diabetes are unaware of continuous glucose monitoring.MORE

How much does it cost to produce insulin?


A recent study sets prices for the future of biosimilars.MORE

Tandem t:slim X2 Approved in Canada


The Tandem t:slim X2 has received Health Canada license with sales expected to begin in Fall 2018. Read on to learn a bit more about the product and to find out if it’s in the running for your next ...MORE

$2 Million Grant to Power Bionic Pancreas Trials


The iLet Bionic Pancreas System is pocket sized device that will be worn similarly to that of an insulin pump, but only requires the patient to enter body weight, and does not require any carbohydrate...MORE

Abbott’s FreeStyle Libre Gains CE Mark In Europe


Earlier this month, Abbott announced that its FreeStyle Libre 2 system had secured CE Mark clearance in the European Union. The system will be launched on a rolling basis throughout Europe, starting i...MORE

How Paige Powered Up


Off the little Seattle island of San Juan, big things are happening in philanthropy — we're seeing an entire community contribute their resources and talents to help raise awareness and funds f...MORE

Tidepool Announces Plans to Create FDA-Regulated Loop


On Monday, October 8, Tidepool announced plans to deliver an officially supported, FDA-regulated Loop app, available via the App Store. MORE

Research Shows Fridges Might Be Destroying Insulin


A 16-month study has shown that 79% of insulin is kept at temperatures outside of the recommended range. Insulin stored in the fridge is at a much higher risk. MORE

5 Takeaways from Diabetics on the Margin


“I think it’s so important that we’re having these kinds of open discussions that people from all different cultures and identities can meet and mix and validate one another. This honestly is th...MORE

People Are Dying from Insulin Rationing – Even TV Dramas Are Talking About It


While TV dramas have the propensity to be — well, dramatic — the details of Abby’s story are not only accurate but also more common than one might believe.MORE

Beyond Type 1 Receives $300,985 Helmsley Charitable Trust Grant for DKA Awareness Campaign


Beyond Type 1 is excited to announce today that we have received a $300,985 grant from The Leona M. and Harry B Helmsley Charitable Trust to power the next phase of our DKA Awareness Campaign.MORE

DiaYogi Dialogues


11 conversations with game changers who teach yoga and live with diabetes.MORE

$10 Million Grant to ViaCyte from Gore Supports Cell-Based Treatment for Diabetes


Today, ViaCyte and W.L. Gore & Associates announced a $10 million investment by Gore into ViaCyte. This is the second multimillion dollar investment by Gore, following a first in 2017.MORE

The Diabetics on the Margin Event in NYC


If you’ve ever looked at the diabetes space and thought, there isn’t anybody who looks like me here!, the Diabetics on the Margin event, presented by Beyond Type 1 in partnership with Ariel Lawren...MORE

CRISPR Therapeutics and ViaCyte’s Strategic Collaboration to Develop Gene‐Edited Stem Cell‐Derived Therapy for Diabetes


Yesterday, CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company that develops transformative gene‐based medicines for serious diseases, and ViaCyte, Inc., a regenerative medicine company,...MORE